Evaluation of the indomethacin-nitroglycerin interaction with positron-emission tomography

Journal of Cardiovascular Pharmacology
E M BednarcyzkM A Munger

Abstract

The hypothesis that local release of prostanoids may contribute to the pharmacologic effect of nitroglycerin (NTG) has long been debated. Results of prostanoid blockade by indomethacin on NTG-induced effects, to date, have been inconclusive. To quantitate the effects of intravenous indomethacin on NTG-induced myocardial blood flow by using positron-emission tomography, we conducted a prospective, controlled, parallel-design study comparing patients with coronary artery disease with healthy volunteers. Eight subjects, four Canadian Class II-III coronary artery disease (CAD) with luminal narrowing of > 80% in a minimum of two vessels, and four healthy volunteers were evaluated. Baseline global myocardial blood flow was equivalent between the groups. NTG produced a 49.3 +/- 4.7% increase in myocardial blood flow in healthy volunteers (p = 0.006) and an -0.5 +/- 19.8% decrease in the group with CAD (p = 0.62 between groups). After indomethacin, both groups had a 24% decline in myocardial blood flow (CAD, p = 0.25; healthy, p = 0.03). One patient with CAD had acute ischemia after indomethacin. The study demonstrated that short-term intravenous indomethacin decreases NTG-induced myocardial blood flow to the same degree in both subjec...Continue Reading

References

Apr 1, 1990·Journal of Thoracic Imaging·D J ConcesR D Tarver
Sep 1, 1980·Journal of Cardiovascular Pharmacology·M SakanashiK I Yonemura
Oct 1, 1984·Circulation·S R BergmannB E Sobel
Dec 1, 1984·Journal of the American College of Cardiology·M D WinnifordL D Hillis
Jan 1, 1980·The American Journal of Cardiology·E MorcillioB Pitt
Mar 1, 1981·The Journal of Clinical Investigation·R I LevinK Tack-Goldman
Nov 12, 1981·The New England Journal of Medicine·P L FriedmanW Grossman
Aug 1, 1993·Circulation·S Ballin, C Louis
Sep 9, 1993·The American Journal of Cardiology·H L Fung

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.